Pulsed Electromagnetic Fields to Reduce Diabetic Neuropathic Pain and Stimulate Neuronal Repair: A Randomized Controlled Trial

Archives of Physical Medicine and Rehabilitation

Volumn 90, Issue 7, 2009, Pages 1102-1109

  Weintraub, Michael I ^a   Herrmann, David N ^b   Smith, A Gordon ^c   Backonja, Misha M ^d   Cole, Steven P ^e  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e EMORY UNIVERSITY   (United States)

Author keywords

Electromagnetic fields; Rehabilitation

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOSIMETRY; DOUBLE BLIND PROCEDURE; ELECTROMAGNETIC FIELD; FEMALE; HUMAN; HUMAN TISSUE; LIMB; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NERVE CONDUCTION; NERVE FIBER; NERVE REGENERATION; NEUROPATHIC PAIN; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT GLOBAL IMPRESSION OF CHANGE; PERIPHERAL NEUROPATHY; PRURITUS; PULSED ELECTRIC FIELD; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SHAM PROCEDURE; SKIN BIOPSY; SLEEP; SYMPTOM; THIGH; VISUAL ANALOG SCALE;

ADULT; AGED; AGED, 80 AND OVER; DIABETIC NEUROPATHIES; DOUBLE-BLIND METHOD; FEMALE; FOOT; HUMANS; MALE; MIDDLE AGED; NERVE FIBERS; NEURAL CONDUCTION; NEURONS; PAIN; SKIN; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 67649398862     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apmr.2009.01.019     Document Type: Article

References (51)

1. Borckardt J.J., Smith A.R., Reeves S.T., et al. Fifteen minutes of left prefrontal repetitive transcranial magnetic stimulation acutely increases thermal pain thresholds in healthy adults. Pain Res Manag 12 (2007) 287-290
2. Andre-Obadia N., Mertens P., Gueguen A., et al. Pain relief by rTMS. Differential effect of current flow but no specific action on pain subtypes. Neurology 71 (2008) 833-840
3. Topper R., Foltys H., Meister I.G., et al. Repetitive transcranial magnetic stimulation of the parietal cortex transiently ameliorates phantom limb pain-like syndrome. Clin Neurophysiol 114 (2003) 1521-1530
4. Schlaier J.R., Eichhammer P., Langguth B., et al. Effects of spinal cord stimulation on cortical excitability in patients with chronic neuropathic pain: a pilot study. Eur J Pain 11 (2007) 863-868
5. Lin V.W., Hsiao I., and Kingery W.S. High intensity magnetic stimulation over the lumbosacral spine evokes antinociception in rats. Clin Neurophysiol 113 (2002) 1006-1012
6. Summers J., Johnson S., Pridmore S., and Oberoi G. Changes to cold detection and pain thresholds following low and high frequency transcranial magnetic stimulation of the motor cortex. Neurosci Lett 368 (2004) 197-200
7. Leo R.J., and Latif T. Repetitive transcranial magnetic stimulation (rTMS) in experimentally induced and chronic neuropathic pain: a review. J Pain 8 (2007) 453-459
8. Khedr E.M., Korb H., Kamel N.F., et al. Longlasting antalgic effects of daily sessions of repetitive transcranial magnetic stimulation in central and peripheral neuropathic pain. J Neurol Neurosurg Psychiatry 76 (2005) 833-838
9. Lefaucheur J.P. New insights into the therapeutic potential of non-invasive transcranial cortical stimulation in chronic neuropathic pain. Pain 122 (2006) 11-13
10. Lefaucheur J.P., Drouot X., Menard-Lefaucheur I., et al. Neurogenic pain relief by repetitive magnetic cortical stimulation depends on the origin and the site of pain. J Neurol Neurosurg Psychiatry 75 (2004) 612-616
11. Veves A., Backonja M., and Malik R.A. Painful diabetic neuropathy: epidemiology, natural history, early diagnosis and treatment options. Pain Med 9 (2008) 660-674
12. Ørstavik J., Namer B., Schmidt R., et al. Abnormal function of C-fibers in patients with diabetic neuropathy. J Neurosci 26 (2006) 11287-11294
13. Waxman S.G. The molecular pathophysiology of pain: abnormal expression of sodium channel genes and its contributions to hyperexcitability of primary sensory neurons. Pain Suppl 6 (1999) S133-S140
14. Cummins T.R., Sheets P.L., and Waxman S.G. The role of sodium channels in nociception: implications for mechanisms of pain. Pain 131 (2007) 243-257
15. Quasthoff S. The role of axonal ion conductances in diabetic neuropathy: a review. Muscle Nerve 21 (1998) 1246-1255
16. Smith A.G., Ramachandran P., Tripp S., and Singleton J.R. Epidermal nerve innervation in impaired glucose tolerance and diabetic-associated neuropathy. Neurology 57 (2001) 1701-1704
17. Polydefkis M., Griffin J.W., and McArthur J. New insights into diabetic polyneuropathy. JAMA 290 (2003) 1371-1376
18. Obrosova I.G. Update on the pathogenesis of diabetic neuropathy. Curr Diab Rep 3 (2003) 439-445
19. Kennedy J.M., and Zochodne D.W. Impaired peripheral nerve regeneration in diabetes mellitus. J Peripher Nerv Syst 10 (2005) 144-157
20. Ishii D.N. Implication of insulin-like growth factors in the pathogenesis of diabetic neuropathy. Brain Res Brain Res Rev 20 (1995) 47-67
21. Jungnickel J., Gransalke K., Timmer M., and Growthe C. Fibroblast growth factor receptor 3 signaling regulates injury-related effects in the peripheral nervous system. Mol Cell Neurosci 25 (2004) 21-29
22. Ekersley L., Ansselin A.D., and Tomlinson D.R. Effects of experimental diabetes on axonal and Schwann cell changes in sciatic nerve isografts. Brain Res Mol Brain Res 92 (2001) 128-137
23. Miyauchi A., Kanje M., Danielsen N., and Dahlin L.V. Role of macrophages in the stimulation and regeneration of sensory nerves by transposed granulation tissue and temporal aspects of the response. Scan J Plast Reconstr Surg 31 (1997) 17-23
24. Veves A., and King G.L. Can VEGF reverse diabetic neuropathy in human subjects?. J Clin Invest 107 (2001) 1215-1218
25. Devor M. Sodium channels and mechanisms of neuropathic pain. J Pain 7 Suppl 1 (2006) S3-S12
26. Eichberg J. Protein kinase C changes in diabetes: is the concept relevant to neuropathy?. Int Rev Neurobiol 50 (2002) 61-82
27. Vincent A.M., Russell J.W., Low P., and Feldman E.L. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev 25 (2004) 612-628
28. Pilla A.A., Muehsam D.J., Markov M.S., and Sisken B.F. EMF signals and ion/ligand binding kinetics: predictions of bioeffective waveform parameters. Bioelectrochem Bioenerg 48 (1999) 27-34
29. Longo F.M., Yang T., Hamilton S., et al. Electromagnetic fields influence NGF activity and levels following sciatic nerve transection. J Neurosci Res 55 (1999) 230-237
30. Fitzsimmons R.J., Ryaby J.T., Mohan S., Magee F.P., and Baylink D.J. Combined magnetic fields increase insulin-like growth factors-II in TE-85 human osteosarcoma dome cell cultures. Endocrinology 136 (1995) 3100-3106
31. Rodeman H.P., Bayrenter K., and Pfleiderer G. The differentiation of normal and transformed human fibroblast in vitro is influenced by electromagnetic fields. Exp Cell Res 189 (1989) 610-621
32. Eguchi Y., Ogiue-Ikeda M., and Ueno S. Control of orientation of rat Schwann cells using an 8-T static magnetic field. Neurosci Lett 351 (2003) 130-132
33. Frahn J., Lantow M., Lupke M., et al. Alteration in cellular functions in mouse macrophages after exposure to 50 Hz magnetic fields. J Cell Biochem 1 (2006) 168-177
34. Zhao M., Bai H., Wang E., Forrester J.V., and McCaig C.D. Electrical stimulation directly induces pre-angiogenic responses in vascular endothelial cells by signaling through VEGF receptors. J Cell Sci 117 (2004) 397-405
35. Markov M.S. Magnetic field therapy: a review. Electromagn Biol Med 26 (2007) 1-23
36. McLean M.J., Holcomb R.R., Wamil A.W., PIckett J.D., and Cavapol A.V. Blockade of sensory action potentials by a static magnetic field in the 10 mT range. Bioelectromagnetics 16 (1995) 20-32
37. Pilla A.A. Mechanisms and therapeutic applications of time-varying and static magnetic fields. In: Barnes F., and Greenebaum B. (Eds). Handbook of biological effects of electromagnetic fields. 3rd ed. (2006), CRC Pr
38. Weintraub M.I., Wolfe G.I., Barohn R.A., et al. Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebo-controlled trial. Arch Phys Med Rehabil 84 (2003) 736-746
39. Timmel C.R., Till U., and Brocklehurst B. Effects of weak magnetic fields on free radical recombination reactions. Mol Phys 95 (1998) 71-89
40. Cantoni O., Sestili P., Fiorani M., and Dacha M. The effect of 50 Hz sinusoidal electric and/or magnetic fields on the rate of repair of DNA single/double strand breaks in oxidatively injured cells. Biochem Mol Biol Int 37 (1995) 681-689
41. Sisken B.F. Effects of pulsed magnetic fields on neurite outgrowth from chick embryos. Bioelectromagnetics 17 (1996) 293-302
42. Kennedy W.R., Wendelschafer-Crabb G., and Johnson T. Quantitation of epidermal nerves in diabetic neuropathy. Neurology 47 (1996) 1042-1048
43. McArthur J.C., Stocks E.A., Hauer P., Cornblath D.R., and Griffin J.W. Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arc Neurol 55 (1998) 1513-1520
44. Herrmann D.N., Griffin J.W., Hauer P., Cornblath D.R., and McArthur J.C. Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology 53 (1999) 1634-1640
45. Kennedy W.R., Wendelschafer-Crabb G., Polydefkis M., and McArthur J.C. Pathology and quantitation of cutaneous innervation. In: Dyck P.J., and Thomas P.K. (Eds). Peripheral neuropathy. 4th ed. 1 (2005), Saunders, Elsevier 869-895
46. Jensen M.P., Friedman M., Bonzo D., and Richards P. The validity of the Neuropathic Pain Scale for assessing diabetic neuropathy pain in a clinical trial. Clin J Pain 22 (2006) 97-103
47. Herrmann D.N., McDermott M.P., Henderson D., et al. Epidermal nerve fiber density, axonal swellings and QST as predictors of HIV distal sensory neuropathy. Muscle Nerve 29 (2004) 420-427
48. Andre-Obadia N., Peyron R., Mertens P., et al. Transcranial magnetic stimulation for pain control: double-blind study of different frequencies against placebo, and correlation with motor cortex stimulation efficacy. Clin Neurophysiol 117 (2006) 1536-1544
49. Gordh T.E., Stubhaug A., Jensen T.S., et al. Gabapentin in traumatic nerve injury pain: a randomized, double-blind, placebo-controlled, cross-over, multi-center study. Pain 138 (2008) 255-266
50. Dworkin R.H., Turk D.C., Farrar J.T., et al. Core outcome measures for chronic pain clinical trial: IMMPACT recommendations. Pain 113 (2005) 9-19
51. Fregni F., Freedman S., and Pasqual-Leone A. Recent advances in the treatment of chronic pain with non-invasive brain stimulation techniques. Lancet 6 (2007) 188-191